EDRH
ALXN

Edmond de Rothschild Holding’s Alexion Pharmaceuticals ALXN Stock Holding History

Edmond de Rothschild Holding’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-350
Closed -$55K – 765
2020
Q4 		$55K Sell
350
-16,652
-98% -$2.14M ﹤0.01% 559
2020
Q3 		$1.95M Buy
17,002
+2,505
+17% +$270K 0.08% 201
2020
Q2 		$1.63M Buy
14,497
+5,600
+63% +$595K 0.07% 201
2020
Q1 		$799K Buy
+8,897
New +$873K 0.04% 230
2019
Q4 		– Hold
0
– – – 621
2018
Q3 		– Sell
-250
Closed -$31K – 784
2018
Q2 		$31K Hold
250
– – ﹤0.01% 643
2018
Q1 		$28K Hold
250
– – ﹤0.01% 684
2017
Q4 		$30K Buy
+250
New +$30.4K ﹤0.01% 685
2017
Q3 		– Sell
-335
Closed -$41K – 872
2017
Q2 		$41K Hold
335
– – ﹤0.01% 673
2017
Q1 		$41K Hold
335
– – ﹤0.01% 670
2016
Q4 		$41K Buy
+335
New +$41K ﹤0.01% 673

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return